2016 Bulletin

Bulletin vol. 30 no. 1 | 25 The Issue • In June 2013, the regional Medicare carrier for Florida, Puerto Rico, and Virgin Islands announced new restrictions to reimbursement for the administration of certain mood and personality measures by neuropsychologists, as well as reimbursement for feedback sessions. 360 Degree Advocacy • Local neuropsychologists contacted their national organizations, who alerted the IOPC. • The IOPC developed a 360 Degree Advocacy Team that included individuals who had played a role in successful advocacy efforts regarding similar issues with Medicare carriers. • The Team coordinated letters from the IOPC, state/regional organizations, and individual neuropsychologists to the regional Medicare carrier. • Later in 2013, the regional Medicare carrier made significant changes in favor of neuropsychology, referencing the IOPC in some of their comments. Dr. Alice Ann Holland is the Research Director for the Neuropsychology Service at Children's Medical Center Dallas (CMCD) and is the neuropsychologist for the CMCD Center for Cancer and Blood Disorders. She also is an Assistant Professor in Psychiatry at the University of Texas Southwestern Medical Center. Dr. Holland heads an active clinical research program investigating genetic and intrapersonal factors influencing neurocognitive outcomes in medically complex children, adolescents, and young adults, with a particular focus on pediatric oncology and rare brain diseases. In addition to oncology, her clinical interests include rare conditions such as empyema, ospoclonus-myoclonus, and infrequent genetic disorders. Dr. Holland has been the recipient of numerous awards from organizations including the American Psychological Association, American Academy of Clinical Neuropsychology, National Register of Health Service Providers in Psychology, Texas Psychological Association, and Dallas Psychological Association. Reference Postal, K.S., Wynkoop, T.F., Caillouet, B., Most, R., Roebuck-Spencer, T., Westerveld, M., Puente, A., & Pliskin, N.H. (2014). 360 Degree Advocacy: A model for high impact advocacy in a rapidly changing healthcare marketplace. The Clinical Neuropsychologist, DOI: 10.1080/13854046.2014.885087 Beth C. Arredondo, Ph.D., ABPP-CN, directs the Neuropsychology Lab at Western State Hospital in Staunton, Virginia, a training site in the University of Virginia/Western State Hospital postdoctoral residency in Clinical Neuropsychology. She completed her doctoral training at Sam Houston State University and internship and postdoctoral training at the University of Massachusetts. Clinical and research interests include psychological and neuropsychological assessment and treatment of patients with comorbid neurological and psychiatric illness and the utility of neuropsychological assessment in criminal forensic settings. She has been a member of the NAN Legislative Action and Advocacy Committee since 2010 and currently serves as co-chair. One Success Story:

• Cover